STRATEGIC ADVISORY SERVICES

Corporate strategy

Business plans

Financial modeling & Valuations

Fundraising

Mergers & Acquisitions

Sales & Marketing Execution Plans

OPERATIONAL EXCELLENCE

Executive-in-Residence

Strategic Advisor

Board Member

Placeholder Image

Industry Focus

PostOak Ventures specializes in the delivery of service solutions to the Biotechnology, Medical Device, Healthcare Technology and Emerging Technology Industries. Together with our customers, we develop long-term strategies to achieve the most advantageous venture performance.

Biotechnology

Biotech & Pharma start-ups are at the center of a unique convergence of competing forces - focusing on science while facing immense financial constraints. With tightening capital markets and increasing regulatory scrutiny - the room for error is growing ever smaller. We work with our Biotech clients to navigate this environment and maximize their both capital and opportunities - increasing speed-to-market, evaluating licensing and commercialization opportunities.


Green Technology - Biomass/BioFuels

Global clean-energy markets are poised to quadruple in the next decade, growing from $55.4 billion in revenues in 2006 to more than $226.5 billion by 2016. Worldwide environmental intiatives, increasing public sector focus under the current administration in the US, and a dramatic increase in both private and public resources to fund green energy projects has propelled this sector to one of the hottest spaces for new ventures today. Our team works with our clients to assess the feasibility of new renewable energy projects, evaluating the carbon neutrality and potential ROI of various biofuel, wind powered, and solar photovoltaic technologies.

Medical Devices

The venture capital industry invested nearly $3.4 billion in device companies in 2008, with start-up firms seeing the greatest increase in investment activity over the previous four years. This trend has come to a dramatic end in recent months with a non-existent IPO market forcing the majority of new money into follow-on investments in these once early, now later-stage firms. With emerging device companies competing for fewer dollars in this more competitive market, putting the right pitch together has never been more critical. We work with our start-up device clients to craft a customized strategy based on their specific development needs with these constraints in mind. We focus on milestone-based growth targets working with our financing partners to secure the growth equity needed for each distinct phase of development.

Healthcare Technology

The Healthcare IT sector is projected to experience major consolidation over the next 3 years. Several large industry players are using the current market dynamics as an opportunity to quickly acquire assets, often at a discount. This impending consolidation presents a unique opportunity for properly positioned firms to distinguish themselves from their competition, surviving as an acquired entity, a select JV, or possibly a stand-alone acquirer of assets. We provide the market intelligence, due diligence and industry research to assist our H.I.T. clients to navigate this unprecedented macro-environment.